Optimization of solid self-dispersing micelle for enhancing dissolution and oral bioavailability of valsartan using Box-Behnken design

被引:15
作者
Goo, Yoon Tae [1 ]
Park, Sun Young [1 ]
Chae, Bo Ram [1 ]
Yoon, Ho Yub [1 ]
Kim, Chang Hyun [1 ]
Choi, Ji Yeh [2 ]
Song, Seh Hyon [3 ]
Choi, Young Wook [1 ]
机构
[1] Chung Ang Univ, Coll Pharm, 84 Heuksuk Ro Dongjak Gu, Seoul 06974, South Korea
[2] York Univ, Dept Psychol, 4700 Keele St, Toronto, ON, Canada
[3] Kyungsung Univ, Coll Pharm, 309 Suyeong Ro Nam Gu, Busan 48434, South Korea
基金
新加坡国家研究基金会;
关键词
Valsartan; Solid self-dispersing micelle; Box-Behnken design; Dissolution; Oral bioavailability; Reduced quantity; DRUG-DELIVERY-SYSTEM; INTESTINAL PERMEABILITY; ATORVASTATIN CALCIUM; ABSORPTION; SMEDDS; TOOL; SOLIDIFICATION; FLUORESCENCE; SPECTROSCOPY; ENHANCEMENT;
D O I
10.1016/j.ijpharm.2020.119483
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel solid self-dispersing micelle (S-SDM) was developed to enhance the oral bioavailability of valsartan (VST) and to reduce the total mass of solidified supersaturable self-microemulsifying drug delivery system (S-SuSMEDDS), composed of Capmul MCM, Tween 80 (T80), Gelucire 44/14 (G44), Poloxamer 407, Florite PS-10 (FLO), and low-substituted hydroxypropyl cellulose B1 (HPC). Excluding oil component from S-SuSMEDDS, SSDM was optimized using a Box-Behnken design with three independent variables: X-1 (T80/G44, 0.63), X-2 (FLO/HPC, 0.41), and X-3 (solid carrier, 177.6 mg); and three response factors: Y-1 (droplet size, 191.9 nm), Y-2 (dissolution efficiency at 15 min, 55.0%), and Y-3 (angle of repose, 32.4'). The desirability function was 0.636, showing an excellent agreement between the predicted and experimental values. With approximately 75% weight of S-SuSMEDDS, no distinct crystallinity of VST was observed in S-SDM, resulting in critical micelle concentration value of 32 mu g/mL. Optimized S-SDM showed an approximate 4-fold improved dissolution (pH 1.2, 500 mL) compared with raw VST. Following oral administration in rats, optimized S-SDM improved relative bioavailability by approximately 235%, 216%, and 127% versus raw VST, Diovan (R) (commercial reference), and S-SuSMEDDS, respectively. Thus, optimized S-SDM could be a selectable candidate for developing water-insoluble drugs in reduced quantity.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Optimization of the Experimental Conditions for the Stability of Nanofluids Using Box-Behnken Design
    Ma, Lin
    Yu, Zhiqiang
    Qing, Shan
    Liu, Yingchun
    Li, Zengen
    Gui, Zhao
    Zhang, Aimin
    NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2017, 9 (11) : 1724 - 1730
  • [22] Flotation Optimization of Ultrafine Microcrystalline Graphite Using a Box-Behnken Design
    Jin, Mingguo
    Xie, Guangyuan
    Xia, Wencheng
    Peng, Yaoli
    INTERNATIONAL JOURNAL OF COAL PREPARATION AND UTILIZATION, 2018, 38 (06) : 281 - 289
  • [23] Boosting Tadalafil Bioavailability via Sono-Assisted Nano-Emulsion-Based Oral Jellies: Box-Behnken Optimization and Assessment
    Ali, Hany S. M.
    Ahmed, Sameh A. A.
    Alqurshi, Abdulmalik A. A.
    Alalawi, Ali M. M.
    Shehata, Ahmed M. M.
    Alahmadi, Yaser M. M.
    PHARMACEUTICS, 2022, 14 (12)
  • [24] Optimization of corona discharge process using Box-Behnken design of experiments
    Das, Dipayan
    Thakur, Rashmi
    Pradhan, Arun Kumar
    JOURNAL OF ELECTROSTATICS, 2012, 70 (06) : 469 - 473
  • [25] Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design
    Kassem, Mohamed A. A.
    ElMeshad, Aliaa N.
    Fares, Ahmed R.
    AAPS PHARMSCITECH, 2017, 18 (04): : 983 - 996
  • [26] Application of Box-Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe
    Yadav, Pragya
    Rastogi, Vaibhav
    Verma, Anurag
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [27] Optimization and characterization of gastroretentive floating drug delivery system using Box-Behnken design
    Rapolu, Kishore
    Sanka, Krishna
    Vemula, Praveen Kumar
    Aatipamula, Vinaydas
    Mohd, Abdul Bari
    Diwan, Prakash V.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (12) : 1928 - 1935
  • [28] Development and Optimization of Solid Lipid Nanoparticle Formulation for Enhanced Solubility of Ceritinib Using Box-Behnken Design
    Suvarsha, Gaddam
    Velmurugan, Ramaiyan
    Reddy, Aduri Prakash
    ASIAN JOURNAL OF PHARMACEUTICS, 2020, 14 (01) : 123 - 132
  • [29] Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design
    Wang, Fengzhen
    Chen, Li
    Jiang, Sunmin
    He, Jun
    Zhang, Xiumei
    Peng, Jin
    Xu, Qunwei
    Li, Rui
    JOURNAL OF LIPOSOME RESEARCH, 2014, 24 (03) : 171 - 181
  • [30] Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
    Hao, Jifu
    Fang, Xinsheng
    Zhou, Yanfang
    Wang, Jianzhu
    Guo, Fengguang
    Li, Fei
    Peng, Xinsheng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6